LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Construction & Landscaping Businesses for Sale
Childcare & Educational Businesses for Sale
Entertainment & Recreation Businesses for Sale
Grocery Stores & Delis for Sale
Service Businesses for Sale
Technology Businesses for Sale
Transport & Shipping Businesses for Sale
Retail Businesses for Sale
Employment & Personnel Businesses for Sale
Printing, Signs & Publishing Businesses for Sale
Retail Franchise Opportunities
Transport & Shipping Franchise Opportunities
Technology Franchise Opportunities
Manufacturing Franchises for Sale
Restaurant Franchises for Sale
Smoke & Vape Shop Franchises for Sale
Warehouse & Storage Franchise for Sale
Real Estate & Property Management Franchise for Sale
Service Franchises for Sale
Construction & Landscaping Franchise Opportunities
Commercial Spaces for Sale or Lease
Industrial Units for Sale or Rent
Medical Office Spaces for Sale or Rent
Commercial Buildings for Sale or Lease
Land & Developments for Sale
Office Buildings for Sale or Rent
Mixed Use Buildings for Sale or Rent
Retail Spaces for Lease or Sale
Apartment Buildings for Sale
Office Spaces for Sale or Rent
An email will be sent to registered email address.
Please select if you are: